研究单位：[1]Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC),Beijing,Beijing,China,100021[2]Hebei Medical University Fourth Hospital[3]Tianjin Medical University Cancer Institute and Hospital[4]Anyang Tumor Hospital[5]The First Affiliated Hospital with Nanjing Medical University[6]Affiliated Hospital of Hebei University[7]Fujian Cancer Hospital[8]Sichuan Cancer Hospital and Research Institute
研究目的：
This phase III trial is designed to explore a higher radiation dose by using IMRT simultaneous integrated boost technique with or without concurrent chemotherapy for esophageal carcinoma with limited lymph node metastasis.
